Catalyst Event
Intuitive Surgical Inc (ISRG) · Earnings Release
From KEDI U.S. Medical AI Index (KUSMAI)
4/21/2026, 12:00:00 AM
Intuitive Surgical's first-quarter 2026 earnings release is scheduled. I estimate Medium importance as earnings reports typically cause significant price movement, so the event is scheduled.
Korean Translation
인튜이티브 서지컬의 2026년 1분기 실적 발표가 예정됨. 실적 발표는 통상적으로 상당한 주가 변동을 야기하므로 '중간' 중요도로 예상되며, 해당 일정은 예정됨.
Related Recent Events
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA's Q1 2027 earnings release is scheduled for May 20, 2026; Medium importance is assigned as earnings typically drive 5-10% volatility, and analysts forecast an EPS of $1.74-$1.76 estimated.
5/20/2026, 12:00:00 AM
Schrodinger Inc (SDGR) · Earnings Release
First quarter 2026 earnings release scheduled. Analysts forecast an EPS of approximately -$0.56. As a major price catalyst, high importance is expected.
5/6/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to report its Q1 2026 earnings, with analysts forecasting revenue of approximately $345.40M and a normalized EPS of -$0.19; medium impact expected from quarterly earnings release, scheduled.
5/5/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
Q1 2026 earnings release and conference call, with low importance estimated due to the routine nature of the announcement, scheduled.
5/5/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet's Q1 2026 earnings release is scheduled; major tech earnings typically cause >=5% price impact, justifying a Medium importance estimate.
4/23/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
The U.S. FDA is expected to make an approval decision on orforglipron, Eli Lilly's oral GLP-1 drug for weight loss, by April 10, 2026, expected; medium importance reflects the potential market expansion for obesity treatments.
4/10/2026, 12:00:00 AM